Jefferies raises Northrop Grumman stock price target on margin outlook By Investing.com

Jefferies raised its price target on Northrop Grumman to $710 from $690 while keeping a Hold, forecasting FY2026 EPS of $27.70 (vs. $28.00 consensus) and segment margin expansion to ~11%; Wells Fargo initiated coverage with an $800 PT and overweight rating. The company won a $127.3M U.S. contract for 28 GQM-163A targets and will supply IR countermeasures to Germany, supporting revenue/margin trajectory; shares have also rallied amid heightened Middle East tensions. Stock valuation shows a P/E of 23.65 and ~17x consensus FY2027 EBITDA (17% premium to its 3-year average, 37% to the market), and management has a 22-year consecutive dividend increase record; earnings are scheduled for April 21.

Analysis

Northrop Grumman’s recent rerating looks driven by a forward-loaded narrative: steady defense demand plus a handful of program-level margin improvements. The non-obvious pressure point is capacity — accelerating production for advanced systems disproportionately benefits precision subcontractors (machining, composite layup, specialty electronics) while creating a bottleneck for system integrators if skilled labor and test facilities can’t scale, compressing gross margins even as revenue rises. Politically driven production schedules create binary catalysts: a funded ramp can deliver outsized FCF in 18–36 months, while an aggressive schedule without matching appropriations or supplier readiness can produce cost creep and margin misses in the next 6–12 months. Finally, the premium multiple already embeds much of the out-year upside, so the marginal buyer is buying convexity to 2027 outcomes rather than certainty in 2024–25 results.

Key Decisions for Investors

• Tactical long with funded hedge — NOC: Buy 12–18 month LEAP calls (target delta ~0.35) financed ~50% by selling 3–6 month OTM calls. Entry on a post-earnings dip >3–5% or if short interest spikes; aim for asymmetric payoff to 2027 margin realization. R/R: limited carry cost, capped upside if rally short-circuits; max loss ~premium paid, upside multiple 3x+ if execution confirms.
• Earnings-focused put protection — NOC: Buy a 3–6 month 10–15% OTM put or put spread ahead of next quarterly report to protect a core long or to short-term hedge long-defense exposure. Cost small vs equity exposure; protects against execution/budgeting misses that would re-rate the premium multiple.
• Relative-value pair — Long small/mid-cap avionics or IR countermeasures supplier (select names with >30% revenue exposure to primes) / Short NOC by equal notional. Timeframe 9–18 months to capture supplier leverage to production ramp while short reduces portfolio-duration to big-prime headline risk. R/R: outperformance potential 20–40% if supplier wins orders; hedges macro/geopolitical reversals.
• Income/volatility harvest — NOC: If holding shares, sell 3–6 month covered calls at 6–8% OTM to harvest dividend yield and compress volatility exposure. Use proceeds to fund tighter put protection or to scale into long LEAPs on pullbacks. R/R: modest upside cap in exchange for yield enhancement and downside buffer.